Odyssey Therapeutics Acquires Quantum Drug Discovery Startup Rahko
In another cross-the-pond deal, US-based Odyssey Therapeutics acquired London-based Rahko, according to reports from The Telegraph. Rahko is developing...
In another cross-the-pond deal, US-based Odyssey Therapeutics acquired London-based Rahko, according to reports from The Telegraph. Rahko is developing...
PRESS RELEASE: POLARISqb, the Durham based developer of the world’s first drug discovery software built for quantum computers, announces...
Catching Sight Current approaches in computational chemistry that may benefit the development of new or better drugs for people...
We use cookies to analyse traffic and improve your experience. Privacy Policy